The number of opioid deaths in D.C. jumped 12 percent to 518 last year, the fifth consecutive year of increases since fentanyl became the predominant drug in overdoses.
No state has gone as far as Florida in restricting gender-affirming care for trans adults. Many patients are now reeling from not being able to access hormone treatments.
Avian flu was found for the first time in U.S. livestock this month, including in cows and a goat. The risk to humans is low, but experts warn against drinking raw milk.
The federal government said that its prescription drug insurance for seniors will cover the popular weight-loss drug to treat patients with heart-related conditions, after the regulators broadened Wegovy’s regulatory label this month.
Contrary to popular belief, dogs aren’t wired to instinctively love their crates. Here’s how experts advise helping them adjust — and why some never will.
U.S. cases of measles, which can cause symptoms like fever, coughs and rashes, are rising. The MMR vaccine is a safe and effective way to prevent infection.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
The FDA approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its kind.
Eli Lilly had expected donanemab to be approved this month, but regulators will hold an advisory committee meeting to scrutinize the drug’s safety and effectiveness.
Winfrey leaves as weight-loss firms grapple with the rise in injectable drugs like Ozempic and Wegovy. WeightWatchers’ shares fell 27 percent after the news.
A new therapy approved by the Food and Drug Administration supercharges the body’s immune system to kill a kind of skin cancer, opening the door to targeting more common tumors.
Charles, now a cancer patient, previously promoted some cancer treatments, such as coffee enemas, that raised the eyebrows of eminent British oncologists.